We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+10.15%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.23B
AUM Growth
+$348M
Cap. Flow
+$172M
Cap. Flow %
7.72%
Top 10 Hldgs %
19.36%
Holding
1,755
New
109
Increased
939
Reduced
649
Closed
58

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$14.5M
2
AMGN icon
Amgen
AMGN
+$11.6M
3
ABBV icon
AbbVie
ABBV
+$10.2M
4
CELG
Celgene Corp
CELG
+$8.88M
5
BIIB icon
Biogen
BIIB
+$7.99M

Sector Composition

Rank Sector Weight
1 Healthcare 24.35%
2 Technology 12.32%
3 Financials 9.33%
4 Industrials 8.44%
5 Consumer Discretionary 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVRI icon
1201
Enviri
NVRI
$621M
$397K 0.02%
14,167
+579
+4% +$15.5K
NWSA icon
1202
News Corp Class A
NWSA
$14.5B
$397K 0.02%
22,045
+4,799
+28% +$82.8K
UTEK
1203
DELISTED
Ultratech Inc.
UTEK
$397K 0.02%
13,697
+6,791
+98% +$180K
BRKL
1204
DELISTED
Brookline Bancorp
BRKL
$395K 0.02%
41,272
+12,506
+43% +$114K
JNS
1205
DELISTED
Janus Capital Group Inc
JNS
$395K 0.02%
31,950
-270
-0.8% -$2.78K
MLKN icon
1206
MillerKnoll
MLKN
$1.5B
$393K 0.02%
13,312
+588
+5% +$17.6K
CAG icon
1207
Conagra Brands
CAG
$7.07B
$392K 0.02%
14,964
-1,165
-7% -$29.1K
SYKE
1208
DELISTED
SYKES Enterprises Inc
SYKE
$391K 0.02%
17,911
-6,514
-27% -$131K
AREX
1209
DELISTED
Approach Resources Inc.
AREX
$391K 0.02%
20,271
+5,917
+41% +$145K
LH icon
1210
Labcorp
LH
$24.3B
$390K 0.02%
4,966
-117
-2% -$9.98K
EXPO icon
1211
Exponent
EXPO
$2.98B
$389K 0.02%
20,076
+524
+3% +$9.9K
GHL
1212
DELISTED
Greenhill & Co., Inc.
GHL
$388K 0.02%
6,695
+507
+8% +$26.5K
LCII icon
1213
LCI Industries
LCII
$2.51B
$387K 0.02%
7,557
+1,919
+34% +$97.7K
MNTA
1214
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$386K 0.02%
21,849
+9,939
+83% +$167K
POM
1215
DELISTED
PEPCO HOLDINGS, INC.
POM
$384K 0.02%
20,067
+512
+3% +$9.71K
ARCB icon
1216
ArcBest
ARCB
$3.44B
$383K 0.02%
11,360
-4,320
-28% -$129K
JWN
1217
DELISTED
Nordstrom
JWN
$383K 0.02%
6,194
+1,247
+25% +$75.1K
AAN.A
1218
DELISTED
The Aaron's Company Inc Class A
AAN.A
$383K 0.02%
13,042
-132
-1% -$3.88K
BWA icon
1219
BorgWarner
BWA
$13.2B
$382K 0.02%
7,755
+305
+4% +$14.1K
HBAN icon
1220
Huntington Bancshares
HBAN
$35.1B
$382K 0.02%
39,603
-1,495
-4% -$13.4K
MASI
1221
DELISTED
Masimo
MASI
$382K 0.02%
13,082
+1,018
+8% +$28.5K
GLBR
1222
DELISTED
Global Brokerage, Inc. Class A Common Stock
GLBR
$382K 0.02%
+2,144
New +$360K
CKP
1223
DELISTED
CHECKPOINT SYSTEMS INC
CKP
$382K 0.02%
24,209
-2,326
-9% -$36.5K
JAZZ icon
1224
Jazz Pharmaceuticals
JAZZ
$15.9B
$381K 0.02%
3,009
+137
+5% +$14.2K
KWR icon
1225
Quaker Houghton
KWR
$2.63B
$381K 0.02%
+4,950
New +$380K

Similar funds

Profund Advisors's Q4 2013 Portfolio in Review

As of Q4 2013, Profund Advisors held 1,755 positions worth $2.23B, up 18% from $1.88B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Profund Advisors deployed $172M of net new capital in Q4 2013, opening 109 new positions and adding to 939 existing holdings. Its largest new stake was Ambev: 287,712 shares worth $2.12M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 22% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was ARM HOLDINGS PLC ADS, an estimated $2.18M trimmed.

  • Profund Advisors's largest Q4 2013 buy was Ambev: 287,712 shares worth $2.12M.
  • Profund Advisors added most to Gilead Sciences in Q4 2013, an estimated $14.5M increase.
  • Profund Advisors's biggest Q4 2013 reduction was ARM HOLDINGS PLC ADS, cutting an estimated $2.18M.
  • Profund Advisors fully exited COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH in Q4 2013, selling an estimated $2.1M.
  • Profund Advisors's ten largest holdings make up 19% of its $2.23B portfolio in Q4 2013.
  • Profund Advisors opened 109 new positions and closed 58 in Q4 2013.
  • Profund Advisors's portfolio value rose 18% quarter-over-quarter to $2.23B.

Based on Profund Advisors's 13F filing for Q4 2013, filed 4 Feb 2014.